Studio Santa Claus Entertainment Co., Ltd. acquired an additional 5.7% minority stake in NexturnBioscience Co., Ltd from pacing, Sohn Young-sook, Peng Mi-sun and Shin Ji-yoon for KRW 9.8 billion.
June 20, 2021
Share
Studio Santa Claus Entertainment Co., Ltd. (KOSDAQ:A204630) agreed to acquire an additional 5.7% minority stake in NexturnBioscience Co., Ltd (KOSDAQ:A089140) from pacing, Sohn Young-sook, Peng Mi-sun and Shin Ji-yoon for KRW 9.8 billion on June 21, 2021. Under the term, Studio Santa Claus Entertainment will acquire 0.68 million shares of NexturnBioscience at KRW 14,400 per share. The transaction was resolved by the board of directors of Studio Santa Claus Entertainment. The transaction is expected to close in June 21, 2021.
Studio Santa Claus Entertainment Co., Ltd. (KOSDAQ:A204630) completed the acquisition of an additional 5.7% minority stake in NexturnBioscience Co., Ltd (KOSDAQ:A089140) from pacing, Sohn Young-sook, Peng Mi-sun and Shin Ji-yoon on June 21, 2021.
Studio Santa Claus Entertainment Co Ltd, formerly Fleet Co Ltd, is a Korea-based company principally engaged in the management of entertainers. The Company is also engaged in making films, television (TV) series and original sound tracks (OSTs) of TV series, video contents and others. The Company distributes its products within domestic market and to overseas markets.
Studio Santa Claus Entertainment Co., Ltd. acquired an additional 5.7% minority stake in NexturnBioscience Co., Ltd from pacing, Sohn Young-sook, Peng Mi-sun and Shin Ji-yoon for KRW 9.8 billion.